219 related articles for article (PubMed ID: 19352388)
41. Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence.
Bellone G; Solerio D; Chiusa L; Brondino G; Carbone A; Prati A; Scirelli T; Camandona M; Palestro G; Dei Poli M
Ann Surg Oncol; 2007 Nov; 14(11):3232-42. PubMed ID: 17682823
[TBL] [Abstract][Full Text] [Related]
42. Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1α in human glioblastoma.
Clara CA; Marie SK; de Almeida JR; Wakamatsu A; Oba-Shinjo SM; Uno M; Neville M; Rosemberg S
Neuropathology; 2014 Aug; 34(4):343-52. PubMed ID: 24612214
[TBL] [Abstract][Full Text] [Related]
43. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.
Yang LY; Lu WQ; Huang GW; Wang W
BMC Cancer; 2006 May; 6():110. PubMed ID: 16650286
[TBL] [Abstract][Full Text] [Related]
44. Angiogenesis and lymphangiogenesis in the spectrum of leprosy and its reactional forms.
Soares CT; Rosa PS; Trombone AP; Fachin LR; Ghidella CC; Ura S; Barreto JA; Belone Ade F
PLoS One; 2013; 8(9):e74651. PubMed ID: 24040306
[TBL] [Abstract][Full Text] [Related]
45. Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers.
Minhajat R; Mori D; Yamasaki F; Sugita Y; Satoh T; Tokunaga O
Pathol Int; 2006 Dec; 56(12):717-23. PubMed ID: 17096728
[TBL] [Abstract][Full Text] [Related]
46. Long-term prognostic significance of neoangiogenesis in breast carcinomas: comparison of Tie-2/Tek, CD105, and CD31 immunocytochemical expression.
Dales JP; Garcia S; Carpentier S; Andrac L; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Charpin C
Hum Pathol; 2004 Feb; 35(2):176-83. PubMed ID: 14991534
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.
Tanaka F; Otake Y; Yanagihara K; Kawano Y; Miyahara R; Li M; Yamada T; Hanaoka N; Inui K; Wada H
Clin Cancer Res; 2001 Nov; 7(11):3410-5. PubMed ID: 11705856
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of parathyroid gland angiogenesis in chronic kidney disease associated with secondary hyperparathyroidism.
Martins P; Schmitt F; Almeida H; Frazão JM
Nephrol Dial Transplant; 2008 Sep; 23(9):2889-94. PubMed ID: 18398016
[TBL] [Abstract][Full Text] [Related]
49. CD105 expression is an independent predictor of survival in patients with endometrial cancer.
Erdem O; Taskiran C; Onan MA; Erdem M; Guner H; Ataoglu O
Gynecol Oncol; 2006 Dec; 103(3):1007-11. PubMed ID: 16854456
[TBL] [Abstract][Full Text] [Related]
50. Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905).
Dales JP; Garcia S; Carpentier S; Andrac L; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Taranger-Charpin C
Br J Cancer; 2004 Mar; 90(6):1216-21. PubMed ID: 15026804
[TBL] [Abstract][Full Text] [Related]
51. Correlation of vascular endothelial growth factor and CD105-microvascular density in primary pterygium.
Zhang J; Zhang M; Li X; Zheng T; Mu G; Liu W; Xie H; Liu X
J Huazhong Univ Sci Technolog Med Sci; 2011 Aug; 31(4):560. PubMed ID: 21823022
[TBL] [Abstract][Full Text] [Related]
52. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
53. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas.
Barresi V; Cerasoli S; Vitarelli E; Tuccari G
Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108
[TBL] [Abstract][Full Text] [Related]
54. Different synovial vasculogenic profiles of primary, rapidly destructive and osteonecrosis-induced hip osteoarthritis. An immunohistochemistry study.
Gurzu S; Turdean SG; Pop ST; Zazgyva A; Roman CO; Opris M; Jung I
Int Orthop; 2017 Jun; 41(6):1107-1112. PubMed ID: 27704157
[TBL] [Abstract][Full Text] [Related]
55. Endoglin (CD105) expression and angiogenesis status in small cell lung cancer.
Takase Y; Kai K; Masuda M; Akashi M; Tokunaga O
Pathol Res Pract; 2010 Nov; 206(11):725-30. PubMed ID: 20619547
[TBL] [Abstract][Full Text] [Related]
56. Laryngeal carcinoma recurrence rate and disease-free interval are related to CD105 expression but not to vascular endothelial growth factor 2 (Flk-1/Kdr) expression.
Marioni G; Giacomelli L; D'Alessandro E; Staffieri C; Guzzardo V; Staffieri A; Blandamura S
Anticancer Res; 2008; 28(1B):551-7. PubMed ID: 18383901
[TBL] [Abstract][Full Text] [Related]
57. Endoglin is necessary for angiogenesis in human ovarian carcinoma-derived primary endothelial cells.
Xu Y; Wang D; Zhao LM; Zhao XL; Shen JJ; Xie Y; Cao LL; Chen ZB; Luo YM; Bao BH; Liang ZQ
Cancer Biol Ther; 2013 Oct; 14(10):937-48. PubMed ID: 23917399
[TBL] [Abstract][Full Text] [Related]
58. Upregulation of endoglin (CD105) expression during childhood brain tumor-related angiogenesis. Anti-angiogenic therapy.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1998; 18(3A):1485-500. PubMed ID: 9673360
[TBL] [Abstract][Full Text] [Related]
59. Gene expression analysis reveals an angiogenic profile in uterine leiomyoma pseudocapsule.
Di Tommaso S; Massari S; Malvasi A; Bozzetti MP; Tinelli A
Mol Hum Reprod; 2013 Jun; 19(6):380-7. PubMed ID: 23355533
[TBL] [Abstract][Full Text] [Related]
60. High immunohistochemical expression of TGF-β1 predicts a poor prognosis in cervical cancer patients who harbor enriched endoglin microvessel density.
Lin H; Huang CC; Ou YC; Huang EY; Changchien CC; Tseng CW; Fu HC; Wu CH; Li CJ; Ma YY
Int J Gynecol Pathol; 2012 Sep; 31(5):482-9. PubMed ID: 22833091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]